Name | NEFROLAYN-NN, OOO |
|---|
INN | 5228057300 |
|---|
KPP | 522801001 |
|---|
OGRN | 1145228000532 |
|---|
OKPO | 43020438 |
|---|
Address | 606650, Nizhegorodskaya Oblast', g. Semenov, ul. Krasnoe Znamya, d. D.26 A, of. OFIS 3 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.10 | Core activity | Hospitals | | 33.13 | Additional activity | Repair of electronic and optical equipment | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | All types of activities | | 86.21 | Additional activity | General practice | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 31.10.2014 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 8 po Nizhegorodskoy oblasti |
|---|
|
NEFROLAYN-NN, OOO (Nizhny Novgorod Oblast; INN 5228057300) was registered on 31 Oct 2014. The company's authorized capital as of July 1, 2012 was 100000 rub. Principal activities of NEFROLAYN-NN, OOO: hospitals (86.10), repair of electronic and optical equipment (33.13), wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of NEFROLAYN-NN, OOO grew over 2023 1.76 times to 22.50 million RUB from 12.75 million RUB over 2022, the company informed. Revenue increased in the accounting period by 13.56% to 226.17 million RUB from 199.16 million RUB over 2022; cost of goods sold grew by 9.26% to 203.58 million RUB from 186.32 million RUB; sales profit went up 1.76 times to 22.59 million RUB from 12.84 million RUB. 2022
Net profit (RAS) of NEFROLAYN-NN, OOO made up 12.75 million RUB over 2022 compared to net loss of 20.08 million RUB over 2021, the company informed. Revenue increased in the accounting period by 15.37% to 199.16 million RUB from 172.62 million RUB over 2021; cost of goods sold decreased by 2.67% to 186.32 million RUB from 191.43 million RUB; sales profit made up 12.84 million RUB compared to sales loss of 18.81 million RUB. 2021
Net loss (RAS) of NEFROLAYN-NN, OOO dropped over 2021 by 44.82% to 20.08 million RUB from 36.39 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 6.98% to 172.62 million RUB from 161.36 million RUB over 2020; cost of goods sold decreased by 2.53% to 191.43 million RUB from 196.39 million RUB; sales loss decreased by 46.31% to 18.81 million RUB from 35.03 million RUB. 2020
Net loss (RAS) of NEFROLAYN-NN, OOO increased 2.51 times to 36.39 million RUB from 14.51 million RUB over 2019, the company informed. Revenue increased in the accounting period by 3.47% to 161.36 million RUB from 155.95 million RUB over 2019; cost of goods sold grew by 16.34% to 196.39 million RUB from 168.80 million RUB; sales loss grew 2.73 times to 35.03 million RUB from 12.86 million RUB. 2019
Net loss (RAS) of NEFROLAYN-NN, OOO dropped over 2019 by 9.47% to 14.51 million RUB from 16.03 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 21.67% to 155.95 million RUB from 128.18 million RUB over 2018; cost of goods sold grew by 18.36% to 168.80 million RUB from 142.62 million RUB; sales loss decreased by 11.17% to 12.86 million RUB from 14.47 million RUB. 2018
Net loss (RAS) of NEFROLAYN-NN, OOO dropped over 2018 2.07 times to 16.03 million RUB from 33.11 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 25.82% to 128.18 million RUB from 101.87 million RUB over 2017; cost of goods sold grew by 7.53% to 142.62 million RUB from 132.63 million RUB; sales loss decreased 2.13 times to 14.47 million RUB from 30.90 million RUB. 2017
Net loss (RAS) of NEFROLAYN-NN, OOO dropped over 2017 by 17.75% to 33.11 million RUB from 40.26 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.90 times to 101.87 million RUB from 53.60 million RUB over 2016; cost of goods sold grew 2.00 times to 117.97 million RUB from 58.88 million RUB; sales loss decreased by 17.33% to 31.24 million RUB from 37.79 million RUB. 2016
Net loss (RAS) of NEFROLAYN-NN, OOO increased 2.38 times to 40.26 million RUB from 16.93 million RUB over 2015, the company informed. Revenue increased in the accounting period 16.13 times to 53.60 million RUB from 3.32 million RUB over 2015; cost of goods sold grew 3.32 times to 58.88 million RUB from 17.74 million RUB; sales loss grew 2.31 times to 37.79 million RUB from 16.34 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|